Announcements Trials
Browse Landscape

Phase

Phase 4 3

Status

Completed 3Recruiting 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 4Gastritis 3Dyspepsia 3Peptic Ulcer 2Stomach Ulcer 1Neoplasms, Plasma Cell 1Neoplasms 1Multiple Myeloma 1Lymphoma 1Leukemia 1Hematologic Neoplasms 1Hematologic Diseases 1Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1

Interventions

Bismuth 3Amoxicillin 3Esomeprazole 2Clarithromycin 2Tetracycline 1Rabeprazole 1Furazolidone 1Berberine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Dyspepsia × Bismuth × Clear all
NCT05742568 2025-07-03

Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology

Xijing Hospital of Digestive Diseases

Phase 4 Completed
124 enrolled
Gastrointestinal

Dyspepsia, Gastritis, Peptic Ulcer, Stomach Neoplasms

NCT04678492 2023-01-31

Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy

Xijing Hospital of Digestive Diseases

Phase 4 Completed
658 enrolled
Gastrointestinal

Dyspepsia, Gastritis, Peptic Ulcer, Stomach Neoplasms

NCT04697186 2023-01-31

Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy

Xijing Hospital of Digestive Diseases

Phase 4 Completed
524 enrolled
Gastrointestinal

Dyspepsia, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡